A study in humans identified the miR-4664-3p as a potential biomarker for coronary artery disease, where it was significantly downregulated in the plasma of CAD patients compared to normal coronary artery controls and ranked among the top ten downregulated microRNAs [Zhong et al. DOI:10.1002/jcla.23020].